首页> 外文会议>World Congress on Heart Disease >Study the effect of spironolacton in airway resistance with impulse oscillometry in patients with CHF (congestive heart failure)
【24h】

Study the effect of spironolacton in airway resistance with impulse oscillometry in patients with CHF (congestive heart failure)

机译:研究CHF患者脉管抗气道阻力的螺旋氮耐药性(充血性心力衰竭)

获取原文

摘要

Introduction: CHF is one of the most important cause of mortality and morbidity in the world.Diuretics such as spironolacton can decreases pulmonary congestion and reduce the amount of fibrosisin CHF patients.The primary end point was to assess the effect of spironolacton on airway resistance with impulseoscillometry, the secondary goal was to localize the site that may be affected more by spironolactonsMethods: It was clinical trial that 24 patients with congestive heart failure (CHF) that had functionalclass II-IV and EF< 40% ,were assessed by impulse oscillometry from October 2010 to December 2010 in sinaclinic hospital. All patients were filled questionnaire and non of them taken spironolactone before.Spironolacton was given to them and they evaluated by IOS 1month later.All data were analyzed by SPSS soft ware versed 16)Result: The age of patient was 61 ± 10 and the age of control was 57 ± 7 years old .The data of oscillometry before and after spironolacton were X5( 0.14 ± 0.05 VS 0.14 ±0.05 , P: 0.93) ,R5( 0.39 ± 0.21 VS 0.39 ±0.15 , P: 0.35) , X20(0.04 ± 0.06 VS 0.06 ±0.06 , P: 0.37) , R20(0.04 ± 0.03 VS 0.06±0.06 , P: 0.37) , Zrs (0.39 ± 0.21 VS 0.39 ±0.15 , P: 0.35).Discussion: Although there was a trend toward reduction of peripheral airway restances in CHF patientsthan controls, spirinolacton had no significant decrease on air way resitance after one month treatmentkey words: spironolacton, oscillometry, CHF .
机译:介绍:CHF是世界上死亡率最重要的原因之一。螺旋氮酰胺如螺母可以降低肺充血和减少纤维化蛋白CHF患者的量。主要终点是评估螺旋氮酰胺对气道阻力的影响血管振动测量,二次目标是通过螺旋乳肌肌肌肌肌肌法定位可能影响的位点:临床试验,24例具有功能性Class II-IV和EF <40%的充血性心力衰竭(CHF)的患者被脉冲示波法评估2010年10月至2010年12月在辛克林医院。所有患者均填充问卷并非替代螺旋酮。在给予它们之前,它们通过iOS 1个以后评估它们。通过SPSS软件探索了16)结果:结果:患者年龄为61±10和年龄对照的是57±7岁。螺酰胺酰胺前后的示波器数据是X5(0.14±0.05 Vs 0.14±0.05,P:0.93),R5(0.39±0.21 Vs 0.39±0.15,P:0.35),X20(0.35),X20( 0.04±0.06 Vs 0.06±0.06,p:0.37),R20(0.04±0.03 Vs 0.06±0.06,P:0.37),Zrs(0.39±0.21 Vs 0.39±0.15,P:0.35)。频道:虽然有趋势为了减少CHF患者患者控制中的外周气道停顿,在一个月的治疗单词:螺旋氮,示波器,CHF后,Spirinolodon在空气方面没有显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号